abstract |
the present invention relates to a new compound (1) having a tumor vascular remodeling effect and / or anti-caf activity (cancer-associated fibroblasts), or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier, and medical use of it. |